Pala Daniele, Clark David, Edwards Christine, Pasqua Elisa, Tigli Laura, Pioselli Barbara, Malysa Piotr, Facchinetti Fabrizio, Rancati Fabio, Accetta Alessandro
Global Research and Preclinical Development, Chiesi Farmaceutici S.p.A Parma 43122 Italy
Charles River Laboratories 8-9 Spire Green Centre Harlow CM19 5TR UK.
RSC Med Chem. 2024 Sep 16;15(11):3862-79. doi: 10.1039/d4md00313f.
We report the characterization of potent and selective ROCK inhibitors identified through a core-hopping strategy. A virtual screening workflow, combining ligand- and structure-based methods, was applied on a known series of ROCK inhibitors bearing an acetamido-thiazole scaffold. The most promising replacement of the central core was represented by a benzoazepinone ring, which was selected as a starting point for a subsequent chemical exploration. The overall design approach exploited previous SARs available for congeneric series and crystallographic information to optimize the hinge-binding group as well as the terminal aromatic moiety interacting with the glycine-rich loop. The introduction of elongated and flexible charged groups led to compound 15, which exhibited sub-nanomolar potencies in biochemical and cellular assays, as well as a remarkable selectivity over PKA. HDX studies not only supported the postulated binding mode of compound 15 but also confirmed the crucial role of specific ROCK peptide segments in driving ligand selectivity.
我们报告了通过核心跳跃策略鉴定出的强效且选择性的ROCK抑制剂的特征。一种结合基于配体和基于结构方法的虚拟筛选工作流程,应用于一系列已知的带有乙酰氨基噻唑支架的ROCK抑制剂。最有前景的核心替换物是苯并氮杂卓酮环,它被选作后续化学探索的起点。整体设计方法利用了同类系列可用的先前构效关系和晶体学信息,以优化铰链结合基团以及与富含甘氨酸环相互作用的末端芳香部分。引入细长且灵活的带电基团得到了化合物15,它在生化和细胞测定中表现出亚纳摩尔级的效力,以及对PKA的显著选择性。氢氘交换研究不仅支持了化合物15假定的结合模式,还证实了特定ROCK肽段在驱动配体选择性方面的关键作用。